Abstract:Abdominal ultrasound imaging is an important method for hepatic schistosomiasis diagnosis and staging. Several ultrasound staging systems have been proposed, each attempting to standardise schistosomal periportal fibrosis (PPF) diagnosis. This review aims to establish the role of ultrasound in the diagnosis and staging of schistosomal PPF, and to map the evolution of ultrasound staging systems over time, focusing on internal validation and external reproducibility. A systematic search was undertaken on 21 st December 2022 considering the following databases: PubMed/MEDLINE (1946-present), Embase (1974-present), Global Health (1973-present), Global Index Medicus (1901-present), and Web of Science Core Collection–Science Citation Index Expanded (1900-present) and the Cochrane Central Register of Controlled Trials (1996-present). Case reports, systematic reviews and meta-analyses, and studies exclusively using transient or shear-wave elastography were excluded. Variables extracted included study design, study population, schistosomal PPF characteristics, and diagnostic methods. The PRISMA-ScR (2018) guidelines were followed to inform the structure of the scoping analysis. The initial search yielded 573 unique articles, of which 168 were removed after screening titles and abstracts, 43 were not retrieved due to full texts not being available online or through inter-library loans, and 170 were excluded during full text review. There were 192 remaining studies eligible for extraction. Of the extracted studies, 61.8% (76/123) of studies that reported study year were conducted after the year 2000. Over half of all extracted studies (59.4%; 114/192) were conducted in Brazil (26.0%; 50/192), China (18.8%; 36/192) or Egypt (14.6%; 28/192). For the species of schistosome considered, 77.6% (149/192) of studies considered S . mansoni and 21.4% (41/192) of studies considered S . japonicum . The ultrasound staging systems used took on three forms: measurement-based, feature-based and image pattern-based. The Niamey protocol, a measurement and image pattern-based system, was the most used among the staging systems (32.8%; 63/192), despite being the most recently proposed in 1996. The second most used was the Cairo protocol (20.8%; 40/192). Of the studies using the Niamey protocol, 77.8% (49/63) only used the image patterns element. Where ultrasound technology was specified, studies after 2000 were more likely to use convex transducers (43.4%; 33/76) than studies conducted before 2000 (32.7%; 16/49). Reporting on ultrasound-based hepatic diagnoses and their association with clinical severity was poor. Just over half of studies (56.2%; 108/192) reported the personnel acquiring the ultrasound images. A small number (9.4%; 18/192) of studies detailed their methods of image quality assurance, and 13.0% (25/192) referenced, discussed or quantified the inter- or intra-observer variation of the staging system that was used. The exclusive use of the image patterns in many studies despite lack of specific acquisition guidance, the increasing number of studies over time that conduct ultrasound staging of schistosomal PPF, and the advances in ultrasound technology used since 2000 all indicate a need to consider an update to the Niamey protocol. The protocol update should simplify and prioritise what is to be assessed, advise on who is to conduct the ultrasound examination, and procedures for improved standardisation and external reproducibility. Schistosomal periportal fibrosis is a form of liver fibrosis caused by a parasitic blood fluke, which is predominantly prevalent in sub-Saharan Africa, but also affects areas of South America and South-East Asia. Ultrasound imaging is the most used method to diagnose schistosomal periportal fibrosis because it is easy to transport, safe to use, and the fibrosis is highly echogenic. Many different systems to stage this fibrosis using ultrasound have been proposed, focused on measuring blood vessels in the liver or identifying features or patterns of echogenicity in the scan that might indicate a certain stage of disease. The Niamey protocol is the most recently proposed of these staging systems, having been published by the World Health Organisation in 1996, which contains guidance for staging of S . mansoni morbidity. This guidance was updated in 2000. In the same year, updated guidance for the staging of S . japonicum morbidity was published by the China Centre for Disease Control (CDC). Both S . mansoni and S . japonicum- focused protocols evolved from the Cairo protocol. Our study aimed to understand how ultrasound has been used to stage schistosomal periportal fibrosis and to investigate how different staging systems have been applied and validated. The studies found were first conducted in 1979, and were mostly conducted in Brazil, -Abstract Truncated-

A-250 Evaluation of Liver Fibrosis in Schistosomiasis Mansoni Using the ELF (Enhanced Liver Fibrosis) Score

Serum CHI3L1 As a Biomarker for Non-invasive Diagnosis of Liver Fibrosis.

The role of point-of-care ultrasound in the assessment of schistosomiasis-induced liver fibrosis: A systematic scoping review

POS0884 THE ENHANCED LIVER FIBROSIS (ELF) SCORE AS A BIOMARKER OF SKIN FIBROSIS IN SYSTEMIC SCLEROSIS

Determination of Serum Levels of YKL-40 and Hyaluronic Acid in Patients with Hepatic Fibrosis Due to Schistosomiasis Japonica and Appraisal of Their Clinical Value.

Circulating Collagen Metabolites and the Enhanced Liver Fibrosis (ELF) Score as Fibrosis Markers in Systemic Sclerosis

Enhanced Liver Fibrosis Score for Diagnosing Liver Fibrosis in Chronic Hepatitis

Using the FIB-4, automatically calculated, followed by the ELF test in second line to screen primary care patients for liver disease

[Expression of Smad Proteins in the Process of Liver Fibrosis in Mice Infected with Schistosoma Japonicum].

Effect of hepatocyte damage in hepatic fibrogenesis of patients infected with Schistosoma japonicum

The Performance of Enhanced Liver Fibrosis (ELF) Test for the Staging of Liver Fibrosis: A Meta-Analysis

A simple noninvasive index to predict significant liver fibrosis in patients with advanced schistosomiasis japonica.

Evaluation of Liver Fibrosis and Portal Hypertension in Chronic Hepatitis B Patients by Acoustic Radiation Force Impulse Elastography

Comparative evaluation of APRI, FIB-4, HFS, and NFS: Scoring tools for liver fibrosis in a Mexican population with MASLD

Prognostic role of ELF test compared to liver biopsy in patients with metabolic dysfunction-associated steatotic liver disease (MASLD)

IgG persistence showed weak clinical aspects in chronic schistosomiasis patients

P- 26 FIBROSIS FREQUENCY IN A COHORT OF METABOLIC FATTY LIVER DISEASE RISK PATIENTS

Preliminary Study on the Evaluation of Liver Fibrosis Using Endoscopic Ultrasound Elastography and Transabdominal Ultrasound Transient Elastography Combined with Strain Ratio

[Value of Shear-Wave Elastography of the Liver and Spleen for Predicting the Risk of Esophageal - Gastric Varices and Bleeding in Patients with Advanced Schistosomiasis].

Sequential Diagnostic Approach Using FIB-4 and ELF for Predicting Advanced Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease

The Relationship Between Serum Insulin-Like Growth Factor-1 and Liver Function in Patients with Schistosomal Liver Fibrosis